HMGB1 and Cognitive impairment: Of note, the levels of the above proteins increased over time, and the increases were more pronounced at 7 months post injection when cognitive impairments were present, implying the underlying relationship between elevated HMGB1 induced by p-tau overexpression and spatial memory disorders.